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innovations, with regard to their impact on patients’ health status. RESULTS: Response 
rate was 78%. The seven most important pharmaceutical innovations reported were 
Angiotensin Converting Enzyme (ACE) inhibitors and angiotensin II antagonists, inhaled 
steroids and β2-agonists, statins, proton pump inhibitors and H2-antagonists, novel 
antibiotics, antiviral drugs for hepatitis  and C and calcium channel blockers. The seven 
most important technological innovations were: magnetic resonance imaging (MRI) and 
computed tomography scanning (CT), balloon angioplasty with stents, Coronary Artery 
Bypass Graft (CABG), gastrointestinal endoscopy, Human Immunodeﬁ ciency Virus 
testing, mammography and Prostate-Speciﬁ c Antigen (PSA) testing. In both cases, inno-
vations that ranked higher were used to treat high-prevalence diseases with a signiﬁ cant 
contribution on the burden of disease for the Greek population. In addition, innovations 
that contributed to improvements in disease diagnoses and management were also 
ranked higher. CONCLUSIONS: the epidemiological proﬁ le of the population, the 
effectiveness of each innovation in terms of clinical effectiveness as well as health-related 
quality of life, and the utility of the innovation in everyday clinical practice constitute 
important determinants of the physicians’ opinions regarding the relative importance of 
medical innovations on the health status of the Greek population.
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OBJECTIVES: To analyze and predict trends in utilization of preventive care services 
in a United States population using a national database. Several national reports and 
evidence in literature indicate disparities in the utilization of preventive care services 
but only few have predicted utilization patterns of preventive care services. METHODS: 
The 2007 Medical Expenditure Panel Survey (MEPS), a national probability sample 
survey of the ambulatory civilian US population, was analyzed to determine demo-
graphic patterns of utilization. Utilization of blood pressure screening, cancer screen-
ing (mammography, colonoscopy/sigmoidoscopy, pap smear and breast), cholesterol 
and dental checkup and ﬂ u vaccination were used as the dependent variables while 
age, gender, race/ ethnicity, annual income insurance status and perceived health status 
were used as independent variables. Descriptive statistics were used to describe the 
population; univariate chi-squared analysis was used to determine group differences 
for the categorical variables. Multivariate logistic regression model was built to predict 
odds of utilization of services. All analyses were carried out using SAS v9.1. RESULTS: 
Utilization of preventive care services was found to be high for blood pressure (n = 
17,959, 89.0%) and cholesterol (n = 14,956, 94.7%) checkup and low for ﬂ u vaccina-
tion (n = 30,964, 21.2%). Signiﬁ cant chi square differences in utilization of preventive 
care services were found for most of the dependent variables (P < 0.001), save for 
colonoscopy/sigmoidoscopy screening. Regression model showed that young women 
(20–30 years) with higher income were more likely to obtain breast exams (OR = 
10.584; CI = 4.312–25.980) compared with young women earning lower income 
(<$20,000). Odds of utilization were nearly similar for all races. However, Hispanics 
were more likely to obtain a colonoscopy/sigmoidoscopy (OR = 3.069; CI = 2.216–
4.250) compared with non-Hispanics. The uninsured generally had lower odds of 
utilization across almost all preventive care services. CONCLUSIONS: This study was 
successful in identifying age, race, income and insurance status-related disparities and 
in predicting preventive care service utilization in a US population. 
HEALTH CARE USE & POLICY STUDIES – Prescribing Behavior & 
Treatment Guidelines
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OBJECTIVES: To evaluate the number and types of pharmacists’ interventions of 
electronic prescriptions at Sultan Qaboos University (SQU) hospital in Oman. 
METHODS: This was a prospective study where interventions on electronic prescrip-
tions over one-year (2009) at SQU hospital were evaluated. a standard data collection 
form was used to capture the data related to drug choice and drug regimen. Clinical 
relevance was deﬁ ned as to whether efﬁ cacy or toxicity was either improved or 
reduced. Clinical relevance was based on the judgments of at least two pharmacists. 
Analyses were performed using descriptive statistics. RESULTS: A total of 1,123 
interventions were recorded out of 186,353 prescriptions (intervention rate/prescrip-
tion = 0.6%) and 454,654 items (intervention rate/item = 0.25%) dispensed. During 
the year, only 3% of the interventions were administrative (absence of doctor’s sig-
nature/wrong patient’s card) while 97% were clinical. The clinical interventions were 
categorized into drug regimen (n = 886; 74%) and drug choice (n = 313; 26%). Almost 
62% (n = 547) of the problems associated with drug regimen were related to wrong 
doses. The three most common drug choice issues included wrong formulations (n = 
107; 34%), wrong drug (n = 62; 20%) and deletion (n = 62; 20%). Efﬁ cacy improved 
in 52% (n = 588) of the cases, avoided toxicity in 29% (n = 324) and avoided unneces-
sary exposure in 19% (n = 211). Interventions prevented organ damage in 1.7% (n = 
20) of the cases, major in 17% (n = 188), moderate in 49% (n = 550) and minor in 
32% (n = 364). The mean time (±SD) spent per prescription was 11 ± 9 minutes. 
CONCLUSIONS: The data show that out-patient pharmacists play an important role 
in drug safety and optimization of pharmaceutical care.
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OBJECTIVES: Adequate levels of medication are critical among elderly patients given 
the existence of co-morbidities and impaired levels of functioning. Using patient data 
collected via a web-based information system, we investigated the average number of 
items prescribed to geriatric patients treated in Acute Geriatric and Remobilisation 
Units (AG/R) in Austria between January 2008 and December 2009. We investigated 
the association of age with medication levels and assessed whether treatment in an 
AG/R led to changes in levels of medication. METHODS: The standardised data set 
developed by QiGG was made available by AG/Rs using the geriatric module of the 
online information system “Healthgate BARS”. We assessed patients’ medication data 
including number of prescribed items at admission and discharge. Baseline character-
istics (including age) were assessed. Additionally, changes in medication prescriptions 
during the stay were documented. RESULTS: Data from 14,923 stays were analyzed. 
Patients were prescribed a mean of 8.4 agents (±3.6) at admission which was signiﬁ -
cantly reduced to a mean of 8.0 (±3.35) at discharge after a mean length of stay of 
18.9 (±14.1) days. a reduction in levels of medication was observed among all age 
groups (young-old: −74, middle-old: 75–84, oldest-old: 85+).The oldest old had the 
lowest mean number of prescriptions at both admission (8.1 ± 3.4) and discharge (7.6 
± 3.1). There was an overall increase in documented changes to prescriptions (either 
in number or type of medications) during this period from 61.1% to 80.1%. CON-
CLUSIONS: The observed reductions in levels of medication across all analyzed 
groups during (in-patient) stays in AG/Rs, as well as the documented changes in 
prescriptions, may suggest increased awareness both of over-prescription and the 
necessity of adequate medication levels in special geriatric care.
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OBJECTIVES: Both observed and unobserved bias in observational claims data are 
controlled with instrumental variable approach. However, it is difﬁ cult to ﬁ nd a valid 
instrument that is strongly correlated with treatment choice but not directly correlated 
with outcomes. In this paper, we derived doctors’ prescribing patterns from the claims 
data and examined their validity. METHODS: Based on U.S. claims data, we assigned 
patients a unique doctor based on the greatest number of ofﬁ ce visits during the 6 
months pre-index period. For each physician, and for each 6-month calendar block 
of time, we estimated the physician preference as the time-varying proportion of 
patients treated with selective serotonin reuptake inhibitors (SSRIs) and serotonin–
norepinephrine reuptake inhibitors (SNRIs) during that interval. We applied Shea’s 
partial R-square method, the Anderson canonical correlation, and Cragg-Donald tests 
to check if doctors’ prescribing patterns were weak instruments. RESULTS: Tests 
showed that doctors’ prescribing patterns are a valid and strong instrument for out-
comes research studies. We showed that patients were more likely to be prescribed 
generic SSRIs relative to non-generic SSRIs if doctors’ prescribing patterns favored 
generic prescription (p = 0.000). Similarly, patients were less likely to be in the SSRIs 
group if doctors’ prescribing patterns favored SNRI prescriptions (p = 0.000). We 
showed that the treatment coefﬁ cient on the adherence model that does not control 
for the unobserved bias was 10% lower than the one that uses the instrumental vari-
able method. CONCLUSIONS: Doctors’ prescribing patterns are important factors 
for prescription decisions. Any outcomes research models such as compliance, adher-
ence or treatment effect studies should incorporate these patterns. Models that fail to 
control for these variables might contain omitted variable bias.
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OBJECTIVES: Because economic evaluations aim to decrease practice variations and 
advocate (cost)-effective interventions, their use in the formulation of practice 
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guidelines for prevention and treatment has gained attention in many developed 
countries. The objective of our study was to investigate to what extent clinical practice 
guidelines consider cost-effectiveness and budget impact according to the most recent 
economic evidence. METHODS: We carried out systematic literature reviews of eco-
nomic evaluations on the ﬁ ve most important medications by means of expenditures 
in the The Netherlands in 2007 (cholesterol-lowering drugs, antihypertensives, proton 
pump inhibitors, long-acting bronchodilators/ inhaled corticosteroids and antidepres-
sants). Consequently, we compared the economic evidence to the recommendations 
of the relevant clinical practice guidelines. RESULTS: Eleven clinical practice guide-
lines were determined to be relevant for the medications under consideration. 
Although the recommendations of each of these guidelines are largely in agreement 
with the most recent economic evidence, 9/11 guidelines hardly considered the cost-
effectiveness of medications. The guidelines ‘Cardiovascular Risk Management’ 
(2006) and ‘Anxiety Disorders’ (2003) systematically regarded cost-effectiveness, but 
their recommendations are not based on the most recent economic evidence. Only the 
guideline ‘Cardiovascular Risk Management’ (2006) considered budget impact to take 
accessibility and affordability constraints into account when considering cost-effec-
tiveness. CONCLUSIONS: Limited or no attention to economic evidence does not 
necessarily lead to ‘wrong’ recommendations. However, the consideration of cost-
effectiveness and budget impact in clinical practice guideline development is needed 
to increase clinician compliance, which in turn could ensure accessibility, affordability 
and quality of care in national health care systems. Furthermore, their consideration 
could harmonise national guidelines with reimbursement decisions. Engaging an eco-
nomic expert in the guideline development process could contribute to the integration 
of the most recent economic evidence in clinical practice guidelines.
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OBJECTIVES: We assessed the real-world anticoagulation thromboprophylaxis pat-
terns in patients undergoing major orthopedic surgery. METHODS: A retrospective 
study (January 1, 2005–December 31, 2007) was conducted using a large hospital 
database linked with outpatient claims. Patients’ demographics, and clinical and 
provider characteristics were compared using Chi-square testing and standardized 
differences. Risk-adjusted event rates were estimated using the Poisson regression 
model. RESULTS: The linked database is comprised of 2280 enrollees, of whom 1769 
met the eligibility criteria. A total of 1552 patients received anticoagulant venous 
thromboembolism (VTE) prophylaxis; 264 of these patients received a combination 
of low molecular-weight heparin and warfarin. Of these patients, 105 (40%) were 
switched between the two monotherapies, whereas 159 (60%) received bridge (over-
lapping) prophylaxis. VTE and major bleeding events were signiﬁ cantly lower for 
bridged patients. However, duration of bridging varied widely. CONCLUSIONS: 
Although there is a beneﬁ t with longer duration of therapy, duration of anticoagula-
tion bridging therapy varies widely and does not appear to be consistent with pub-
lished guidelines. 
HEALTH CARE USE & POLICY STUDIES – Quality of Care
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OBJECTIVES: In the Hungarian emergency departments (EDs) it became necessary 
to hire nurses with wider competencies but there is no a nationally uniﬁ ed policy and 
training for them. Our aim was to determine the knowledge about the physical 
examinations of nurses working at EDs with the different scope of practices (triage 
nurses, departmental heads of nurses, general nurses). METHODS: Twenty-three 
Hungarian emergency departments was examined, a questionnaire was completed by 
the departments’ nurses (n = 301) and physicians (n = 159). SPSS 16.0 software was 
used for statistical analysis, khi-square test was used to determine correlations. 
RESULTS: A total of 71.5% of nurses have learned in some way the physical examina-
tions wich did not present signiﬁ cant difference between the groups determined by 
nurses’ scope of practice (p = 0,228). Triage nurses and the departmental heads of 
nurses examine signiﬁ cantly more times for example the cardiovascular system (P < 
0.001) and touch the stomach (p = 0.032) than departments’ general nurses. Emer-
gency physicians would make the nurses done more diagnostical duties than they 
presently do in everyday practice for example examining the cardiovascular system (P 
< 0.001) and the chest (p = 0.001). CONCLUSIONS: Even majority of emergency 
nurses have learned in some way the physical examinations, they admitted a low rate 
of usage in the everyday practice. In contrary, physicians would place the physical 
examinations among the tasks of nurses possessing adequate qualiﬁ cation, thus exten-
sion of the competencies of nurses is necessary.
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OBJECTIVES: Pharmacists as sales representatives inﬂ uence on prescribing physi-
cians. This research is focused on their characteristics valued by physicians to improve 
their communication and the effectiveness of cooperation. METHODS: The sample 
includes 203 physicians from Central Serbia: 78 general practitioners, 125 specialists, 
72 males and 131 females. It was used the scale of attitudes on pharmacists sale 
representatives regarding the provision of drug information. The instrument includes 
20 items and the ﬁ ve-point Likert type scale. RESULTS: The results show correlations 
between the following variables: the impression of responsible pharmacist when visit-
ing physicians is in a positive correlation with proper terminology used by pharmacist 
(r = 0.650, p < 0.01), the argued presentation of preparations (r = 0.652, p < 0.01), 
the systematic exposure of drug materials (r = 0.626, p < 0.01), concise information 
(r = 0.583, p < 0.01), and visual eye contact during presentation (r = 0.648, p < 0.01); 
the impression of incompetence was positively correlated to fearful pharmacist per-
formance (r = 0.654, p < 0.01) and uncertainty in an interaction with physicians (r = 
0.792, p < 0.01), and negatively correlated to an argued information on preparation 
(r = −0.523, p < 0.01). CONCLUSIONS: The results show a correlation between 
pharmacists’ characteristics as sales representatives observed by physicians. Pharma-
cists as sales representatives proved competence and responsability only in assertive 
communication, as well as in concise and argued presentation with a live visual eye 
contact as essential for nonverbal communication.
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OBJECTIVES: Many different methods exist for managing surgical bleeding complica-
tions (SBCs) and reducing transfusions during procedures. The techniques utilized are 
dependent on institutional policies, resulting in highly variable clinical and economic 
outcomes between different institutions. Our objective was to review the current lit-
erature on the quality and costs of SBC interventions to prevent and manage transfu-
sions during surgeries and provide recommendations on future directions for quality 
improvement of SBCs. METHODS: A comprehensive review was conducted using 
Ovid, Pubmed and Scopus databases with the following keywords: quality improve-
ment (QI), blood loss, transfusion, hemostasis and costs. Inclusion criteria included 
English language, publication between 1999 and 2010, and studies where the key 
words were the primary endpoints. a total of 1331 abstracts were reviewed. RESULTS: 
A variety of blood loss prevention techniques were identiﬁ ed including autologous 
transfusion, pharmacological and non-pharmacological interventions. Studies suggest 
that bleed prevention (BP) algorithms incorporating a combination of interventions in 
the pre, peri and post-operative periods have the greatest potential to minimize trans-
fusions. Most studies assessing the economic impact of BP interventions did not 
include the cost of staff time, other resources beyond blood acquisition cost and longer 
term complications. The exclusion of these components may underestimate the actual 
costs of transfusions and may have implications in assessing true cost-effectiveness of 
BP interventions. Consensus exists that transfusions can and should be prevented 
during surgery, yet there’s a lack of agreement on the optimal use of interventions for 
blood loss management. CONCLUSIONS: Wide agreement on the necessity of avoid-
ing transfusion exists, yet proven methods for minimizing SBCs are underused. Mul-
tifaceted algorithms for minimizing SBCs show promising results where they have been 
used. Future QI projects should focus on reducing variation in practices through the 
development of evidence based standards and guidelines for the effective use of BP 
interventions. 
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OBJECTIVES: The primary objective was to evaluate the knowledge of the drugstore 
consumers from the Pilot Plan Plano Piloto and workers of ANVISA, for the regulation 
of prices of medicines. The speciﬁ c objectives were to assess the knowledge of the 
populations on PMC, different price of generic medicines, estimate monthly expenses 
of the two samples and a preliminary comparative analysis between the two samples. 
METHODS: The study developed is a cross descriptive and analytical study. Based in 
the application of different questionnaires for to assess the knowledge about regulation 
of prices of medicines and consumption habits of consumers interviewed in the door 
of the drugstore and workers of ANVISA. The research was conducted by sampling 
